{"schema":"sb.node.v1","id":"sb:e/9e0afc3668e701a1225b4b19","kind":"entity","label":{"text":"parkinson","locale":"en"},"identity":{"anchor":"label:en:parkinson","strength":"label"},"asOf":{"knowledgeCutoff":"2026-10-08T23:32:17.032179+00:00","snapshot":"deploy f53c83974898cc97526b6050ab92612cf967bfc1"},"lens":{"kind":"public"},"build":{"plane":"projected","builtFrom":["entity_graph.slim.json","entity_receipts (deploy asset)","event_graph.json","truth_records (deploy asset)","corroborated_record.json"],"rule":"node-projection.entity@v1"},"standing":{"evidence":{"supporting":118,"separatePublishers":55,"basis":"documents that mention the subject and the outlets that carried them; a mention is evidence the referent is in use, not evidence about any claim"},"admission":{"state":"canonical","reason":"entity graph provenance 'curated'; the node carries no promotion receipt in v1","policy":"EQ-PROMOTION (receipt not carried)"},"disposition":{"state":"served","reason":"public record"},"validity":{"from":"2026-05-16","to":"2026-10-07","basis":"first and last day we saw it mentioned; not the subject's own lifetime"},"measurement":{"state":"partial","blind":["assertion coverage 0.331: about 67% of mentions carry no typed assertion"]}},"dimensions":{"domains":["auto"],"activeDays":35,"assertions":{"regulatory-approval":12,"award":7,"meeting-visit":5,"launch-release":5,"utterance":4,"acquisition":2}},"up":[],"upNote":"An entity is a root: it is contained by nothing. Pan out by following R.","children":{"count":10,"byKind":{"observation":10},"withheld":{"state":"withheld","count":2,"reason":"2 receipts withheld: no source link (the same rule the topic record applies)"},"items":[{"id":"sb:o/df3e6bb7829a6026b254b0cd","kind":"observation","label":"Clinical Trials Arena · 2026-10-07 · Parkinson’s disease market expected to reach $7.2bn across the 7MM by 2033","url":"https://www.clinicaltrialsarena.com/analyst-comment/parkinsons-disease-market-expected-to-reach-7-2bn-across-the-7mm-by-2033/"},{"id":"sb:o/bf3152d3a320d6ca297b92fb","kind":"observation","label":"Endpoints News · 2026-10-06 · Roche enlists Alector in Parkinson's deal, paying $100M upfront","url":"https://endpoints.news/roche-enlists-alector-in-parkinsons-deal-paying-100m-upfront/"},{"id":"sb:o/387c440425b113a206414253","kind":"observation","label":"The Medical News · 2026-10-06 · Managing misfolded proteins to prevent Parkinson’s disease","url":"https://www.news-medical.net/news/20261006/Managing-misfolded-proteins-to-prevent-Parkinsone28099s-disease.aspx"},{"id":"sb:o/404d9f5a668a350bb6632846","kind":"observation","label":"The Clinical Trial Vanguard · 2026-10-06 · Lundbeck’s Lu AF28996 gains 2+ hours daily ON-time in Parkinson’s Phase Ib","url":"https://www.clinicaltrialvanguard.com/news/lundbecks-lu-af28996-gains-2-hours-daily-on-time-in-parkinsons-phase-ib/"},{"id":"sb:o/e3c678c244df23528b34f3cb","kind":"observation","label":"CBS News · 2026-10-04 · Alan Alda on fighting Parkinson's with laughter","url":"https://www.cbsnews.com/news/alan-alda-on-fighting-parkinsons-with-laughter/"},{"id":"sb:o/b4320a5f8a0feab4692ff648","kind":"observation","label":"BBC News · 2026-10-01 · Son who used AI to help save mum's life hopes case unlocks clues for other Parkinson's patients","url":"https://www.bbc.co.uk/news/articles/cmy0zewj483wo?at_medium=RSS&at_campaign=rss"},{"id":"sb:o/60ac66982d8a6d4f99f857a9","kind":"observation","label":"STAT News · 2026-09-29 · STAT+: AbbVie wins FDA nod for Parkinson’s pill","url":"https://www.statnews.com/2026/09/28/biotech-news-abbvie-wins-fda-nod-for-parkinsons-pill/?utm_campaign=rss"},{"id":"sb:o/576223a002933b9f097d0890","kind":"observation","label":"European Medical Journal · 2026-09-29 · AbbVie wins FDA nod for Parkinson’s disease drug","url":"https://www.emjreviews.com/emj-gold/news/abbvie-wins-fda-nod-for-parkinsons-disease-drug/"},{"id":"sb:o/0ee49e3b46bd551499947e74","kind":"observation","label":"Daily Sabah economy · 2026-09-28 · More REM sleep may lower risk of Parkinson’s, dementia: Study","url":"https://www.dailysabah.com/life/health/more-rem-sleep-may-lower-risk-of-parkinsons-dementia-study"},{"id":"sb:o/b442df4234fe09aecd4d2801","kind":"observation","label":"Medical Daily · 2026-09-28 · AbbVie's Once-Daily Parkinson's Pill Juvmo Wins FDA Approval, with Nausea, Dizziness, and Headache Common in Trials","url":"https://www.medicaldaily.com/juvmo-tavapadon-fda-approval-parkinsons-side-effects-479174"}],"cursor":null,"order":"newest first; we keep the 10 newest receipts for this entity. Its other observations are counted in standing.evidence.supporting but are not addressable in v1"},"relations":{"count":10,"byKind":{"co-mentioned":10},"items":[{"kind":"relation","label":"co-mentioned with alzheimer (41 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/f4936b72d8082b5a76494462"},{"kind":"relation","label":"co-mentioned with fda (24 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/83191a204449ea66de31e5d6"},{"kind":"relation","label":"co-mentioned with ai (23 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/4d03d259ef6ee295ce9845d4"},{"kind":"relation","label":"co-mentioned with china (16 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/1c0054d676cf9d7208e4c360"},{"kind":"relation","label":"co-mentioned with clinical trial (15 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/89634b7d87567cf31f391a47"},{"kind":"relation","label":"co-mentioned with united kingdom (15 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/abf84250dda737a072a6a042"},{"kind":"relation","label":"co-mentioned with trump (14 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/88883148f6018261f279d6c0"},{"kind":"relation","label":"co-mentioned with united states (12 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/6be501e2fd65336b81639317"},{"kind":"relation","label":"co-mentioned with buy (11 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/bed378c3ff0a895ede89b907"},{"kind":"relation","label":"co-mentioned with genetic engineering (11 documents)","role":"co-mentioned","relationKind":"co-mentioned","members":2,"id":"sb:r/09dc1fbc08c3a4f201527915"}],"cursor":null,"order":"situations first, then claims (the subject's own maintained record, then site-wide corroborated clusters; each label ends with its standing), then co-mentions by shared documents, descending. Co-mentions are the ten strongest the entity graph keeps per entity"},"edge":{"state":"continues"},"links":{"rest":"/api/v1/node/e/9e0afc3668e701a1225b4b19","mcp":"traverse {\"id\":\"sb:e/9e0afc3668e701a1225b4b19\"}","page":"/entity/parkinson/"},"limits":{"levelsPerCall":1,"pageSize":10,"maxPageSize":50,"membersMax":50,"statement":"One level per call: depth is 1 and only 1, and there is no whole-graph dump. pageSize 1-50 (default 10); a page limit is a cursor, never an edge. Members are listed up to 50. At most 60 traverse calls a minute per caller (runaway-loop protection, not a meter). One knowledge cutoff is served: the deploy's."},"actions":[{"verb":"unfold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/9e0afc3668e701a1225b4b19\",\"level\":\"children\"}"},{"verb":"fold","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/9e0afc3668e701a1225b4b19\"}"},{"verb":"panOut","lit":false,"effect":"read","layer":"cantina","reason":"An entity is a root: it is contained by nothing. Pan out by following R."},{"verb":"follow","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/9e0afc3668e701a1225b4b19\",\"level\":\"relations\"}"},{"verb":"receipts","lit":false,"effect":"read","layer":"cantina","reason":"receipts are the observations below this node; unfold to reach them"},{"verb":"edge","lit":true,"effect":"read","layer":"cantina","call":"traverse {\"id\":\"sb:e/9e0afc3668e701a1225b4b19\"}"},{"verb":"asOf","lit":false,"effect":"read","layer":"cantina","reason":"v1 serves one knowledge cutoff, this deploy's; walking an earlier cutoff needs retained history (EQ-REPLAY), which v1 does not keep"},{"verb":"switchObserver","lit":false,"effect":"read","layer":"cantina","reason":"the public record is the same for every observer; traversal through a Watch's lens is not served in v1"},{"verb":"readOriginal","lit":false,"effect":"read","layer":"cantina","reason":"no translation is applied on this node; every label is the source's own text"},{"verb":"save","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"saving applies to a configured Watch; configure one around this node first (free), then save it"},{"verb":"deliver","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"delivery applies to a saved Watch"},{"verb":"format","lit":false,"effect":"watch-declaration","layer":"workshop","reason":"output format applies to a saved Watch"},{"verb":"deltaR","lit":false,"effect":"read","layer":"workshop","reason":"Delta R needs a saved Watch with a previous reading"},{"verb":"read","lit":false,"effect":"read","layer":"docking-bay","reason":"one-time Reads are parked until the Commander decides their shape (#938)"}]}